Literature DB >> 25249668

We can change the natural history of type 2 diabetes.

Lawrence S Phillips1, Robert E Ratner2, John B Buse3, Steven E Kahn4.   

Abstract

As diabetes develops, we currently waste the first ∼10 years of the natural history. If we found prediabetes and early diabetes when they first presented and treated them more effectively, we could prevent or delay the progression of hyperglycemia and the development of complications. Evidence for this comes from trials where lifestyle change and/or glucose-lowering medications decreased progression from prediabetes to diabetes. After withdrawal of these interventions, there was no "catch-up"-cumulative development of diabetes in the previously treated groups remained less than in control subjects. Moreover, achieving normal glucose levels even transiently during the trials was associated with a substantial reduction in subsequent development of diabetes. These findings indicate that we can change the natural history through routine screening to find prediabetes and early diabetes, combined with management aimed to keep glucose levels as close to normal as possible, without hypoglycemia. We should also test the hypothesis with a randomized controlled trial.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25249668      PMCID: PMC4170125          DOI: 10.2337/dc14-0817

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  77 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

2.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

Authors:  C Weyer; C Bogardus; D M Mott; R E Pratley
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

3.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

4.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

5.  Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61.

Authors:  Stephen Colagiuri; Carole A Cull; Rury R Holman
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

6.  Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.

Authors:  Edmond A Ryan; Sharleen Imes; Clarissa Wallace
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients.

Authors:  Michael Alvarsson; Göran Sundkvist; Ibe Lager; Marianne Henricsson; Kerstin Berntorp; Eva Fernqvist-Forbes; Lars Steen; Gunilla Westermark; Per Westermark; Thomas Orn; Valdemar Grill
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

Review 8.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

9.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

Authors:  Tim Heise; Leszek Nosek; Birgitte Biilmann Rønn; Lars Endahl; Lutz Heinemann; Christoph Kapitza; Eberhard Draeger
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

View more
  23 in total

1.  Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine: An American Perspective.

Authors:  Eric P Smith; Robert M Cohen
Journal:  J Diabetes Sci Technol       Date:  2015-02-17

2.  The effect of photobiomodulation therapy on nonsurgical periodontal treatment in patients with type 2 diabetes mellitus: a randomized controlled, single-blind, split-mouth clinical trial.

Authors:  Seda Sevinç Özberk; Hasan Gündoğar; Mesut Özkaya; İbrahim Levent Taner; Kamile Erciyas
Journal:  Lasers Med Sci       Date:  2019-10-23       Impact factor: 3.161

Review 3.  Application of Disease Etiology and Natural History to Prevention in Primary Health Care: A Discourse.

Authors:  Franklin White
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

4.  Preclinical Evaluation of Poly(HEMA-co-acrylamide) Hydrogels Encapsulating Glucose Oxidase and Palladium Benzoporphyrin as Fully Implantable Glucose Sensors.

Authors:  Rachel M Unruh; Jason R Roberts; Scott P Nichols; Soya Gamsey; Natalie A Wisniewski; Michael J McShane
Journal:  J Diabetes Sci Technol       Date:  2015-06-17

5.  Waist circumference and dysglycaemia: new insights and additional questions, but do not miss the opportunity to measure it!

Authors:  Caterina Conte
Journal:  Intern Emerg Med       Date:  2022-08-30       Impact factor: 5.472

6.  Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.

Authors:  Silvio E Inzucchi; Catherine M Viscoli; Lawrence H Young; Karen L Furie; Mark Gorman; Anne M Lovejoy; Samuel Dagogo-Jack; Faramarz Ismail-Beigi; Mary T Korytkowski; Richard E Pratley; Gregory G Schwartz; Walter N Kernan
Journal:  Diabetes Care       Date:  2016-07-27       Impact factor: 19.112

7.  Therapeutic Inertia in People With Type 2 Diabetes in Primary Care: A Challenge That Just Won't Go Away.

Authors:  Nemin Adam Zhu; Stewart B Harris
Journal:  Diabetes Spectr       Date:  2020-02

8.  Postpartum screening after gestational diabetes mellitus: Aiming for universal coverage.

Authors:  Nikhil Tandon; Yashdeep Gupta; Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

9.  Evaluation of Non-Laboratory and Laboratory Prediction Models for Current and Future Diabetes Mellitus: A Cross-Sectional and Retrospective Cohort Study.

Authors:  Chang Ho Ahn; Ji Won Yoon; Seokyung Hahn; Min Kyong Moon; Kyong Soo Park; Young Min Cho
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

10.  The Association of Serum Uric Acid with Beta-Cell Function and Insulin Resistance in Nondiabetic Individuals: A Cross-Sectional Study.

Authors:  Peng Yu; Li Huang; Zhihan Wang; Xiaoyu Meng; Xuefeng Yu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-14       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.